The E-Prescribing Software
Revolution: 100+ Key Stats
2026 Market Intelligence Report
From $5.98B today to $59.92B by 2035 — a comprehensive data intelligence brief on the world's fastest-growing health IT segment.
$5.98B
Global Market Size
2025
2025
25.92%
CAGR
2026–2035
2026–2035
2.6B
E-Prescriptions Sent
in USA (2024)
in USA (2024)
97%
NHS England EPS
Adoption Rate (2025)
Adoption Rate (2025)
Market Size & Growth
$59.92B
Projected global ePrescribing market value by 2035 (Precedence Research)
25.92%
CAGR of global ePrescribing market 2026–2035 (Precedence Research)
$3.306B
Global e-prescribing market size in 2026 (Business Research Insights)
$2.6B
Global market value in 2024, growing at 22.6% CAGR through 2034 (GMI)
$38.5B
Expected global e-prescribing market by 2033 from $3.5B in 2023 (Market.us)
27.1%
CAGR of global e-prescribing market 2024–2033 (Market.us)
United States Market
1.39M
Prescribers using e-Rx in 2025 (+4% YoY)
30.5B
Surescripts transactions in 2025 (+12% YoY)
2.6B
Electronic prescriptions in USA (2024)
$82
Avg. patient savings per Rx via Real-Time Benefit (2024)
Adoption & Patient Safety
80%+
Prescriptions in developed countries now transmitted electronically (Business Research Insights)
55%
Reduction in medication errors achieved through e-prescribing adoption
7,000+
Deaths annually in US attributed to preventable medication errors (AMCP)
$77B+
Annual cost of drug-related morbidity & mortality in the US (AMCP)
1.5M
Preventable adverse drug events annually in US hospitals & clinics (IOM)
42.5→6.6
Error rate drop (per 100 Rx) after e-prescribing adoption in community practices (Medical Economics)
EPCS & Regulatory Landscape
2010
DEA interim rule legalises EPCS in USA
2011
First EPCS transaction sent over Surescripts
2015
EPCS becomes legal in all 50 US states
2021
CMS mandates EPCS for Medicare Part D; 74% prescribers enabled
2023
CMS begins EPCS enforcement (70% threshold)
2025
84.4% of US prescribers enabled; 30.5B total network transactions
2026
50+ states with EPCS legislation; DEA telemedicine rules made permanent
Technology & AI Integration
52%
Improvement in medication accuracy from AI-driven prescribing tools in 2025 (Business Research Insights)
74%
Cloud-based prescribing platform deployment rate in 2024, improving scalability 50%
58%
Mobile prescribing adoption rate among physicians in 2025
4.1B
Surescripts Sig IQ instructions delivered in 2024 — double the 1.9B in 2023
34 sec
Average prior authorization approval time via Surescripts Touchless PA (down from 1+ hour)
68%
EHR integration growth enhancing clinical decision support systems in 2024
Global Adoption Highlights
97%
NHS England EPS — 1.13B of 1.16B items dispensed electronically in 2024/2025 (NHSBSA)
80%+
Japan healthcare institutions expected to implement e-prescribing by 2025 (Medical DX Plan)
15,000
Canadian pharmacies on PrescribeIT national e-prescribing platform (McKesson Canada)
29.4%
Asia Pacific CAGR through 2033 — fastest-growing region globally (Persistence MR)
Cost Savings & Efficiency
$140–240B
Estimated 10-year healthcare savings from e-prescribing implementation (Surescripts/PMC study)
$1,000+
Average patient savings per specialty medication via Real-Time Prescription Benefit in 2024
3–3.5%
Reduction in electronic prescribers' pharmacy costs due to preferred formulary & generic use
47%
Improvement in opioid prescription monitoring compliance via EPCS integration
14 min
Time saved per patient via AI-powered electronic prior authorization workflows (DAW Systems)
38%
Reduction in prescription fraud achieved via controlled substance e-prescribing (EPCS)